Colorectal cancer is the third leading cause of cancer deaths among both men and women in the United States. However, clinical advances in screening and treatment paradigms for colorectal cancer are improving outcomes for these patients. Colorectal cancer CME and CE is essential for clinicians to stay current with the evolving treatment options for this disease.
Important recent shifts in the treatment paradigm include the expanding role of targeted therapies and immunotherapy in addition to traditional chemotherapy for colorectal cancer. Continuing education regarding the optimal use of each of these available treatment options is critical and includes appropriate patient selection, optimal dosing and administration, and best practices for monitoring for adverse events.
Colorectal cancer CME is vital to developing and increasing the clinical skills, knowledge, and professional performance needed by the healthcare team to effectively provide high-quality care for patients with this disease.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.